Who makes Shen Pu Yang Gan Wan?

Shen Pu Yang Gan Wan is developed by Taipei Medical University WanFang Hospital.

What development phase is Shen Pu Yang Gan Wan in?

Shen Pu Yang Gan Wan is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Shen Pu Yang Gan Wan

Taipei Medical University WanFang Hospital · FDA-approved active Small molecule Quality 2/100

Shen Pu Yang Gan Wan, marketed by Taipei Medical University WanFang Hospital, is a traditional Chinese medicine with a key composition patent expiring in 2028. The drug's market position and primary indication are not specified, but it benefits from being currently marketed and protected by a key patent. The primary risk is the patent expiry in 2028, which could lead to increased competition and potential revenue erosion.

At a glance

Generic name	Shen Pu Yang Gan Wan
Sponsor	Taipei Medical University WanFang Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Shen Pu Yang Gan Wan CI brief — competitive landscape report
Shen Pu Yang Gan Wan updates RSS · CI watch RSS
Taipei Medical University WanFang Hospital portfolio CI